Healius Limited trades on the Australian Securities Exchange under the ticker symbol HLS, representing the parent corporate entity that owns the Healius Pathology network. Public equity valuations fluctuate continuously during active trading sessions based on live market supply and demand, macroeconomic healthcare trends, and corporate earnings reports, requiring investors to check real-time financial platforms for the exact prevailing stock price.